Having graduated with a joint honours degree in Psychology and Philosophy (2:1) from the University of Oxford, I worked as a volunteer Research Assistant and as a support worker on an acute psychiatric ward. This led to an interest in clinical research, particularly in the area of relapse prevention in schizophrenia-spectrum psychosis.
In 2009 I completed a Master’s degree (with Distinction) at the University of Manchester, which included a research dissertation entitled Measuring beliefs about weight gain in young people with early episodes of psychosis: an adaptation of the Revised Illness Perceptions Questionnaire. I then worked as a Research Associate at the University of Manchester, initially on the MIDAS trial (an RCT comparing integrated Motivational Interviewing and Cognitive Behavioural Therapy to treatment as usual in those with co-morbid substance misuse and psychosis) and later in a short term position in the Clinical Psychology Department, supporting applications for external grant funding.
In 2011, I was awarded an MRC Doctoral Training Grant PhD Studentship entitled Identifying relapse risk in psychosis using 'basic symptoms' and smartphone technology, supervised by Prof Christine Barrowclough, Dr Richard Drake, Prof Richard Emsley and, more recently, Prof Sandra Bucci. I completed the PhD over the subsequent eight years, including two periods of maternity leave, passing my viva (Ai) in November 2019.
I subsequently worked on the DAWN-P study (Digital Assessment of Wellness in New Parents), investigating the feasibility, acceptability and validity of using a smartphone app to screen for parental depression in the postnatal period. In my current Research Associate role at Greater Manchester Mental Health NHS Foundation Trust, I am applying for external grant funding to continue and expand on my previous work:
- Investigating the role of basic symptoms and smartphone technology in the early identification of relapses of schizophrenia spectrum psychosis.
- Examining the optimal design and implementation of digital screening for postnatal depression in new pareents.